S𝛃RT.
Combining TGF-beta inhibition and SBRT may enhance the immunogenicity of radiation to sites of metastatic breast cancer.
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Comments
Post a Comment